PD GENEration: Advancing Research, Empowering Lives

Shared from parkinson.org. PD GENEration: Mapping the Future of Parkinson’s Disease is an international Parkinson’s Foundation research study that has enrolled more than 20,000 people with Parkinson’s disease (PD) since its launch six years ago. Study data has already...

Study shows how Parkinson’s drug disrupts the gut microbiome

Shared from southampton.ac.uk.     New research by the University of Southampton has revealed how a commonly prescribed Parkinson’s disease drug disrupts the gut microbiome, potentially causing health complications. The Southampton scientists, working with colleagues...

FDA Approves Onapgo

Shared from drugs.com.     Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that the U.S. Food and Drug...

4 Parkinson’s Advances: How Research Is Improving Treatment

Shared from myparkinsonsteam.com.     In the past 10 years, researchers have discovered a lot of new information about Parkinson’s disease and found ways to significantly improve symptoms. However, many people with Parkinson’s still need additional treatment...

PD GENEration: Mapping the Future of Parkinson’s Disease

Shared from parkinson.org. Join the Study PD GENEration: Mapping the Future of Parkinson’s Disease is a global research study that provides genetic testing and genetic counseling at no cost for people diagnosed with Parkinson’s disease (PD). People can participate by...